These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20558109)

  • 21. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
    Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
    Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet apheresis affects prothrombin time and plasminogen levels in healthy donors.
    Beyan C; Kaptan K; Savaşçi S; Ifran A; Oztürk Y; Okmen B
    Transfus Apher Sci; 2005 Aug; 33(1):47-50. PubMed ID: 15953764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The post-platelet 100,000 count: effects of platelet collection and future.
    Jaben EA; Gandhi MJ
    J Clin Apher; 2011; 26(1):53-5. PubMed ID: 21312259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
    Goodnough LT; Ali S; Despotis G; Dynis M; DiPersio JF
    Vox Sang; 1999; 76(1):43-9. PubMed ID: 9933853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
    Zeiler T; Gritzka D; Karger R; Kretschmer V
    Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation.
    Feys HB; Pottel H; Coene J; Vandewalle G; Vandekerckhove P; Compernolle V
    Vox Sang; 2016 Nov; 111(4):431-433. PubMed ID: 27509321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the use of a platelet-counting tool in plateletpheresis.
    Ho TF; Yang BS; Huang YT; Hung CT
    Vox Sang; 1999; 76(4):226-30. PubMed ID: 10394142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors.
    Weisbach V; Friedlein H; Glaser A; Zingsem J; Zimmermann R; Eckstein R
    Transfusion; 1999 Aug; 39(8):889-94. PubMed ID: 10504126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mice housed in groups of 4-6 exhibit a diurnal surge in their platelet count.
    Hartley PS
    Platelets; 2013; 24(5):412-4. PubMed ID: 22812592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for rapid mobilization of platelets from the spleen during intensive plateletpheresis.
    Lee EJ; Schiffer CA
    Am J Hematol; 1985 Jun; 19(2):161-5. PubMed ID: 4003388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic profile of platelets during reconstitution of platelet counts after apheresis.
    Thiele T; Braune J; Dhople V; Hammer E; Scharf C; Greinacher A; Völker U; Steil L
    Proteomics Clin Appl; 2016 Aug; 10(8):831-8. PubMed ID: 27040998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fingerstick blood samples in platelet donor screening: reliability and impact on predict yield programs.
    Randels MJ; Strauss RG; Raife TJ
    J Clin Apher; 1997; 12(3):105-9. PubMed ID: 9365861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6.
    Kanabrocki EL; Sothern RB; Messmore HL; Roitman-Johnson B; McCormick JB; Dawson S; Bremner FW; Third JL; Nemchausky BA; Shirazi P; Scheving LE
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):37-42. PubMed ID: 10725981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative optical determination of the viability of platelet concentrates.
    Lee VS; Tarassenko L; Bellhouse BJ
    J Biomed Eng; 1992 Jan; 14(1):27-32. PubMed ID: 1569736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.